STAT3 and hepatocellular carcinoma: Additionally, in HCCLM3 hepatocellular carcinoma cells, the isoprenoid antibiotic ascochlorin increased the sensitivity to doxorubicin treatment by directly inhibiting binding of STAT3 to SNAI1 promoter [25].